| BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 卷:24 |
| Scaffold-switching: An exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates | |
| Article | |
| Moraski, Garrett C.1,3  Oliver, Allen G.1  Markley, Lowell D.1  Cho, Sanghyun2  Franzblau, Scott G.2  Miller, Marvin J.1  | |
| [1] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA | |
| [2] Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL 60612 USA | |
| [3] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA | |
| 关键词: Antituberculosis; Imidazo[1,2-a]pyridine; Imidazo[1,2-a]pyrimidine; 5,6-Fused bicyclic system; Scaffold hopping; | |
| DOI : 10.1016/j.bmcl.2014.05.062 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
A set of 5,6-fused bicyclic heteroaromatic scaffolds were investigated for their in vitro anti-tubercular activity versus replicating and non-replicating strains of Mycobacterium tuberculosis (Mtb) in an attempt to find an alternative scaffold to the imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrimidines that were previously shown to have potent activity against replicating and drug resistant Mtb. The five new bicyclic heteroaromatic scaffolds explored in this study include a 2,6-dimethylimidazo[1,2-b]pyridazine-3-carboxamide (7), a 2,6-dimethyl-1H-indole-3-carboxamide (8), a 6-methyl-1H-indazole-3-carboxamide (9), a 7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide (10), and a 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide (11). Additionally, imidazo[1,2-a]pyridines isomers (2 and 12) and a homologous imidazo[1,2-a]pyrimidine isomer (6) were prepared and compared. Compounds 2 and 6 were found to be the most potent against H(37)Rv Mtb (MIC's of 0.1 mu M and 1.3 mu M) and were inactive (MIC >128 mu M) against Staphylococcus aureus, Escherichia coli and Candida albicans. Against other non-tubercular mycobacteria strains, compounds 2 and 6 had activity against Mycobacterium avium (16 and 122 mu M, respectively), Mycobacterium kansasii (4 and 19 mu M, respectively), Mycobacterium bovis BCG (1 and 8 mu M, respectively) while all the other scaffolds were inactive (>128 mu M). (C) 2014 Elsevier Ltd. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_bmcl_2014_05_062.pdf | 862KB |
PDF